Related Experiment Video
Updated: Dec 12, 2025
10:44
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
Published on: November 13, 2017
6.7K
Integrated Array Chip for High-Throughput Screening of Species Differences in Metabolism
Xiaoni Ai1, Lin Zhao1, Yingyuan Lu1
1State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Analytical Chemistry
|August 14, 2020
Summary
This study introduces an integrated array chip (IAC) to assess species-specific drug metabolism and anticancer effects. The novel platform aids in selecting appropriate animal models for human drug development, improving drug discovery efficiency.
Area of Science:
- Pharmacology
- Biotechnology
- Drug Metabolism
Background:
- Species differences in drug metabolism complicate accurate prediction of efficacy and toxicity in humans.
- In vitro assays integrating metabolic competence and cellular effects are crucial for understanding these differences.
- Existing methods lack the high throughput, simplicity, and low sample consumption needed for industrial drug testing.
Purpose of the Study:
- To develop a novel co-culture platform, the integrated array chip (IAC), for evaluating species differences in metabolism-induced drug responses.
- To utilize the IAC for assessing metabolism-induced anticancer bioactivity as a case study.
- To enable the selection of animal models that best mimic human drug responses.
Main Methods:
- Development of an IAC combining a micropillar chip for liver microsome immobilization and a microwell chip for 3D tumor cell culture.
- Optimization of microsomal encapsulation parameters using specific chip designs and agarose spots.
- Validation of the IAC's feasibility using model prodrugs, image-based bioactivity detection, and mass spectrometry (MS)-based metabolite analysis.
Main Results:
- Successfully optimized parameters for liver microsome encapsulation on the micropillar chip.
- Demonstrated the IAC's capability to evaluate metabolism-induced anticancer bioactivity.
- Validated the platform's performance with model prodrugs, showing accurate metabolite analysis and bioactivity detection.
- Utilized a species-specific IAC to identify suitable animal models for human drug response prediction.
Conclusions:
- The developed integrated array chip (IAC) offers a promising co-culture platform for identifying species-specific metabolic differences.
- The IAC facilitates the selection of relevant animal models, thereby accelerating drug discovery and development.
- This technology has the potential for widespread use in industrial settings for drug efficacy and toxicity assessments.
